Lonsurf | Trifluridine and Tipiracil (download only)

Regular price $0.00

Lonsurf (trifluridine and tipiracil) tablets, is used to treat patients with metastatic bowel cancer who have previously been treated with other treatments that have not worked or when other treatments are not suitable.
 
Lonsurf is a type of chemotherapy which belongs to a group of medicines called 'cytostatic antimetabolite medicines'.
 
Is Lonsurf available on the Pharmaceutical Benefits Scheme (PBS) as a subsidised treatment?
  • Lonsurf has been approved by the Therapeutic Goods Administration (TGA) for use in Australia and has received a positive recommendation from the Pharmaceutical Benefits Advisory Committee (PBAC) to be listed on the PBS as a subsidised treatment, but is yet to be listed.

Download the Consumer Medicine Information (CMI) for Lonsurf.